COST PLUS DRUGS
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

COST PLUS DRUGS Trademark

Serial Number: 97307445 • Registration: 7582440

COST PLUS DRUGS is a trademark filed by Mark Cuban Cost Plus Drug Company, PBC on March 11, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Mark Cuban Cost Plus Drug Company, PBC (31 trademarks)

8712 W Fair Dr
Littleton, CO 80123

Entity Type: 03

Trademark Details

Filing Date

March 11, 2022

Registration Date

November 26, 2024

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 26, 2024 NRCS
REGISTERED-SUPPLEMENTAL REGISTER
Nov 26, 2024 R.SR
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Oct 30, 2024 CNTA
EXAMINER'S AMENDMENT ENTERED
Oct 29, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 29, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 29, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 29, 2024 CNEA
USE AMENDMENT ACCEPTED
Oct 22, 2024 IUAA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 1, 2024 TEME
AMENDMENT TO USE PROCESSING COMPLETE
Sep 20, 2024 AUPC
ASSIGNED TO LIE
Sep 20, 2024 ALIE
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 13, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 13, 2024 ERFR
USE AMENDMENT FILED
May 9, 2024 IUAF
TEAS AMENDMENT OF USE RECEIVED
May 9, 2024 EAAU
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Feb 12, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Feb 12, 2024 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 15, 2023 GNFN
FINAL REFUSAL E-MAILED
Nov 15, 2023 GNFR
FINAL REFUSAL WRITTEN
Nov 15, 2023 CNFR
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 28, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 28, 2023 GNSL
SUSPENSION LETTER WRITTEN
Apr 28, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 10, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 10, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 10, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 28, 2022 GNRN
NON-FINAL ACTION E-MAILED
Dec 28, 2022 GNRT
NON-FINAL ACTION WRITTEN
Dec 28, 2022 CNRT
ASSIGNED TO EXAMINER
Dec 22, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 16, 2022 NWOS
NEW APPLICATION ENTERED
Mar 15, 2022 NWAP